Baseline Platelet Count Predicts Infarct Size and Mortality after Acute Myocardial Infarction
Hämostaseologie · 01.06.2026 · 46 (03) · 179-188
DOI: 10.1055/a-2299-0130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hämostaseologie, erschienen am 01.06.2026. Verfasst von Alexander Dutsch und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Myocardial Infarction, Percutaneous Coronary Intervention, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: European Research Council under the European Union's Horizon 2020 Research and Innovation Programme, Else-Kröner-Fresenius-Stiftung, Deutsche Forschungsgemeinschaft (DFG).
Abstract (Originalsprache)
Introduction
Platelets greatly contribute to cardiovascular diseases. We sought to explore the association of platelet counts with infarct size and outcome in patients presenting with acute ST-segment elevation MI (STEMI) treated with primary percutaneous coronary intervention (PPCI). Methods and Results In this retrospective study, we grouped 1,198 STEMI patients into tertiles (T) based on platelet count on admission: T1 = 102–206 [109 platelets/L] (n = 402), T2 = 207–259 [109 platelets/L] (n = 396), and T3 = 260–921 [109 platelets/L] (n = 400). Primary endpoint was 1-year all-cause mortality. Patients with highest platelet counts on admission showed the greatest area at risk and infarct size: area at risk (median) was 22.0% (interquartile range [IQR]: 12.0–39.8%) in T1, 21.0% (IQR: 11.0–37.1%) in T2, and 26.0% (IQR: 14.9–45.0%) of the left ventricle in T3 (p = 0.003); final infarct sizes after 7 to 14 days were as follows: 10.0% (IQR: 2.0–21.0%) in T1, 9.0% (IQR: 2.0–20.7%) in T2, and 12.0% (IQR: 3.0–27.3%) of the left ventricle in T3 (p = 0.015) as serial imaging revealed. At 1 year, 16 all-cause deaths occurred in T1, 5 in T2, and 22 in T3 (log-rank test, p = 0.006). After adjustment, T1 and T3 were associated with all-cause 1-year mortality (T1: hazard ratio [HR] = 3.40, 95% confidence interval [CI] = 1.23–9.54, p = 0.02; T3: HR = 3.55, 95% CI = 1.23–9.78, p = 0.01) compared with T2. At 5 years, all-cause mortality remained numerically higher in the T1 and T3.
Conclusions
In patients with STEMI undergoing PPCI, low and high blood platelet levels on admission were associated with increased long-term mortality (Fig. 1).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Munich, Germany.
- German Centre for Cardiovascular Research (DZHK e.V.), Partner Site Munich Heart Alliance, Munich Germany.
Förderung
- European Research Council under the European Union's Horizon 2020 Research and Innovation Programme
- Else-Kröner-Fresenius-Stiftung
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
Dutsch, A., Graesser, C., Novacek, S., Krefting, J., Schories, V., Niedermeier, B., Voll, F., Kufner, S., Xhepa, E., Joner, M., Cassese, S., Schunkert, H., Ndrepepa, G., Kastrati, A., Kessler, T., & Sager, H. B. (2026). Baseline Platelet Count Predicts Infarct Size and Mortality after Acute Myocardial Infarction. Hämostaseologie, 46(03), 179-188. https://doi.org/10.1055/a-2299-0130
Vancouver
Dutsch A, Graesser C, Novacek S, Krefting J, Schories V, Niedermeier B, et al. Baseline Platelet Count Predicts Infarct Size and Mortality after Acute Myocardial Infarction. Hämostaseologie. 2026;46(03):179-188. doi:10.1055/a-2299-0130
BibTeX
@article{Dutsch2026,
author = {Dutsch, Alexander and Graesser, Christian and Novacek, Sophie and Krefting, Johannes and Schories, Viktoria and Niedermeier, Benedikt and Voll, Felix and Kufner, Sebastian and Xhepa, Erion and Joner, Michael and Cassese, Salvatore and Schunkert, Heribert and Ndrepepa, Gjin and Kastrati, Adnan and Kessler, Thorsten and Sager, Hendrik B},
title = {Baseline Platelet Count Predicts Infarct Size and Mortality after Acute Myocardial Infarction},
journal = {Hämostaseologie},
year = {2026},
volume = {46},
number = {03},
pages = {179--188},
doi = {10.1055/a-2299-0130}
}
EUVIMED